top of page
Similing Team

Meet The Team

Our experts have proven track records in strategy and implementation. We bring the rare ability to integrate understanding of board level business objectives with technician level execution. Our experts have direct operating experience with every phase of product and company development. A list of consultants and resumes are available upon request.

Seraphim Founders

Gary Gamerman MS, JD, President

Gary brings insights developed through his 30+ years’ experience in scientific, executive, regulatory, quality, legal, commercial and manufacturing  operations and business development roles. He has been part of the founding and operational leadership of multiple drug and device companies, an FDA/CBER reviewer, and an attorney in the FDA/Life Sciences practices of leading international law firms.  Gary is a trusted advisor to start-up, major and international companies, NIH, DoD, universities, foundations and venture firms in the development, commercialization, licensing and regulation of medical devices pharmaceuticals, and biologics.

Seraphim Team

Ari Gamerman, Vice President of Business Development

Ari Gamerman is the Vice President of Business Development at Seraphim Life Sciences, where he leads a team of experts specializing in the life sciences industry. With a lifelong sales background and extensive supply chain logistics experience, Ari has developed a vast network of connections and deep insights into the industry. He has worked closely with importing and exporting pharmaceuticals, API, intermediates, medical devices, and nutraceuticals globally, finding innovative solutions to complex challenges. Ari's passion for building lasting relationships with clients and partners, and his dedication to driving results, make him an invaluable asset to the Seraphim Life Sciences team.

Seraphim Affiliate Consultants

Seraphim has a global network of Senior Affiliate Consultants providing the expertise and knowledge that comes from decades of hands-on experience in industry and at regulatory authorities.

bottom of page